Privacy Policy

Last Updated: March 2026

Information We Collect

When you submit a case review form, we collect: your name, email address, phone number, state of residence, and information about your GLP-1 drug use and vision loss diagnosis. We also collect standard web analytics data (pages visited, browser type, IP address).

How We Use Your Information

Your contact information and case details are used to: (1) evaluate your potential eligibility for GLP-1 NAION litigation; (2) connect you with attorneys in our referral network; and (3) contact you regarding your inquiry. We do not sell your personal information to third parties for marketing purposes unrelated to legal services.

Sharing Your Information

We share your information with attorneys and law firms in our referral network who may be able to assist with your GLP-1 NAION claim. By submitting our form, you consent to this sharing for the purpose of legal case evaluation. We may also disclose information as required by law.

TCPA Consent

By submitting your phone number, you consent to be contacted by us and our attorney network partners via telephone (including automated calls), text message, and email at the number and address you provide. Message and data rates may apply. You may opt out at any time.

Data Security

We implement reasonable security measures to protect your information. However, no internet transmission is 100% secure. We cannot guarantee absolute security of information transmitted via the internet.

Cookies

We use cookies and similar tracking technologies for website analytics and to improve user experience. You can disable cookies in your browser settings, though this may affect site functionality.

Your Rights

You may request access to, correction of, or deletion of your personal information by contacting us through the contact page. California residents have additional rights under the CCPA.

Changes to This Policy

We may update this Privacy Policy periodically. The date at the top of this page indicates when it was last revised. Continued use of the site after changes constitutes acceptance of the updated policy.

Did Ozempic, Wegovy, or another GLP-1 drug cause your vision loss? You may qualify for compensation. Check Eligibility →